Market Snapshot
S&P Futures
3,914.75
Dow Futures
31,478
Nasdaq Futures
12,132.75
Autolus Therapeutics plc
(NASDAQ:AUTL)
$2.5
$0.14
5.93%
Autolus Therapeutics plc Chart
AUTL Stock Price Today
Autolus Therapeutics plc (AUTL) stock rallied over 5.93% intraday to trade at $2.50 a share on NASDAQ. The stock opened with a gain of 7.76% at $2.37 and touched an intraday high of $2.7, rising 5.93% against the last close of $2.36. The stock went to a low of $2.37 during the session.
Stock Snapshot
$2.36
Prev. Close
210.93 Million
Market Cap
$2.37
Day Low
$2.37
Open
82.02 Million
Number of Shares
$2.7
Day High
-
P/E ratio
-1.85
EPS (TTM)
3.41
Cash Flow per Share
6.41
Free Float in %
3.36
Book Value
225,626
Volume
Autolus Therapeutics plc Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2022-06-23 | $2.37 | $2.7 | $2.37 | $2.5 | 225,600 |
| 2022-06-22 | $2.32 | $2.466 | $2.32 | $2.36 | 92,100 |
| 2022-06-21 | $2.3 | $2.434 | $2.3 | $2.39 | 109,100 |
| 2022-06-17 | $2.08 | $2.26 | $2.08 | $2.22 | 185,100 |
| 2022-06-16 | $1.99 | $2.09 | $1.96 | $2.06 | 328,600 |
| 2022-06-15 | $2.31 | $2.45 | $2 | $2.04 | 239,300 |
| 2022-06-14 | $2.29 | $2.31 | $2.19 | $2.25 | 147,800 |
| 2022-06-13 | $2.57 | $2.57 | $2.24 | $2.28 | 206,000 |
| 2022-06-10 | $2.78 | $2.79 | $2.45 | $2.56 | 366,800 |
| 2022-06-09 | $2.82 | $2.86 | $2.76 | $2.78 | 78,900 |
Contact Details
Company Information
Employees-
Beta1.61
Sales or Revenue2.33 Million
5Y Sales Change6.60%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
About Company
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma. It also focuses on developing AUTO5, a hematological product candidate, which is in preclinical development. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.
Frequently Asked Questions
What is the current Autolus Therapeutics plc (AUTL) stock price?
Autolus Therapeutics plc (NASDAQ: AUTL) stock price is $2.5 as of the last check on Thursday, June 23. During the trading session, AUTL stock reached the peak price of $2.7 while $2.37 was the lowest point it dropped to.
AUTL's industry and sector of operation?
The NASDAQ listed AUTL is part of Biotechnology industry that operates in the broader Health Care sector. Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma.
Who are the executives of AUTL?
Mr. Andrew J. Oakley
Sr. VP & CFO
Dr. Lucinda Crabtree Ph.D.
VP of IR, Corp. Communications, Bus. Strategy & Planning
Mr. Vishal Mehta
VP & Head of Clinical Operations
Mr. Brent Rice
VP & Chief Commercial Officer
What is the AUTL stock price today?
AUTL stock traded closed the last session at $2.5, which is $0.14 or 5.93% lower than its previous close of $2.36. AUTL's current trading price is 27.55% lower than its 52-week high of $7.90 where as its distance from 52-week low of 1.96% is -68.35%.
How many employees does AUTL have?
Number of AUTL employees currently stands at -. AUTL operates from The MediaWorks, 191 Wood Lane White City, London W12 7FP, United Kingdom.
Link for AUTL official website?
Official Webiste of $AUTL is: https://www.autolus.com
How do I contact AUTL?
AUTL could be contacted at AUTL operates from The MediaWorks, 191 Wood Lane White City, London W12 7FP, United Kingdom, or at phone #44 20 3829 6230 and can also be accessed through its website.
How many shares of AUTL are traded daily?
AUTL stock volume for the day was 225,626 shares while in the previous session number of AUTL shares traded was 225,600 . The average number of AUTL shares traded daily for last 3 months was 218.47 Thousands.
How much did AUTL change today?
The percentage change in AUTL stock occurred in the recent session was 5.93% while the dollar amount for the price change in AUTL stock was $0.14.
What price range AUTL stock been trading in?
In the recent session, the day high for AUTL stock was $2.7 while the low for AUTL stock touched on the day was $2.37.
What is the market cap of AUTL currently?
The market value of AUTL currently stands at 210.93 Million with its latest stock price at $2.5 and 82.02 Million of its shares outstanding.